These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 20406759)
1. Association between blood lead and the risk of amyotrophic lateral sclerosis. Fang F; Kwee LC; Allen KD; Umbach DM; Ye W; Watson M; Keller J; Oddone EZ; Sandler DP; Schmidt S; Kamel F Am J Epidemiol; 2010 May; 171(10):1126-33. PubMed ID: 20406759 [TBL] [Abstract][Full Text] [Related]
2. Blood Lead, Bone Turnover, and Survival in Amyotrophic Lateral Sclerosis. Fang F; Peters TL; Beard JD; Umbach DM; Keller J; Mariosa D; Allen KD; Ye W; Sandler DP; Schmidt S; Kamel F Am J Epidemiol; 2017 Nov; 186(9):1057-1064. PubMed ID: 29020133 [TBL] [Abstract][Full Text] [Related]
3. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Kamel F; Umbach DM; Lehman TA; Park LP; Munsat TL; Shefner JM; Sandler DP; Hu H; Taylor JA Environ Health Perspect; 2003 Aug; 111(10):1335-9. PubMed ID: 12896855 [TBL] [Abstract][Full Text] [Related]
4. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology. Beard JD; Engel LS; Richardson DB; Gammon MD; Baird C; Umbach DM; Allen KD; Stanwyck CL; Keller J; Sandler DP; Schmidt S; Kamel F Environ Int; 2016 May; 91():104-15. PubMed ID: 26923711 [TBL] [Abstract][Full Text] [Related]
5. Lead exposure as a risk factor for amyotrophic lateral sclerosis. Kamel F; Umbach DM; Hu H; Munsat TL; Shefner JM; Taylor JA; Sandler DP Neurodegener Dis; 2005; 2(3-4):195-201. PubMed ID: 16909025 [TBL] [Abstract][Full Text] [Related]
6. A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study. Wu MT; Kelsey K; Schwartz J; Sparrow D; Weiss S; Hu H Environ Health Perspect; 2003 Mar; 111(3):335-41. PubMed ID: 12611663 [TBL] [Abstract][Full Text] [Related]
7. The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Hu H; Wu MT; Cheng Y; Sparrow D; Weiss S; Kelsey K Environ Health Perspect; 2001 Aug; 109(8):827-32. PubMed ID: 11564619 [TBL] [Abstract][Full Text] [Related]
8. Case-control study of environmental toxins and risk of amyotrophic lateral sclerosis involving the national ALS registry. Talbott EO; Malek AM; Arena VC; Wu F; Steffes K; Sharma RK; Buchanich J; Rager JR; Bear T; Hoffman CA; Lacomis D; Donnelly C; Mauna J; Vena JE Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):533-542. PubMed ID: 38591179 [TBL] [Abstract][Full Text] [Related]
9. Lead burden and psychiatric symptoms and the modifying influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism: the VA Normative Aging Study. Rajan P; Kelsey KT; Schwartz JD; Bellinger DC; Weuve J; Sparrow D; Spiro A; Smith TJ; Nie H; Hu H; Wright RO Am J Epidemiol; 2007 Dec; 166(12):1400-8. PubMed ID: 17823382 [TBL] [Abstract][Full Text] [Related]
10. Blood levels of trace metals and amyotrophic lateral sclerosis. Peters TL; Beard JD; Umbach DM; Allen K; Keller J; Mariosa D; Sandler DP; Schmidt S; Fang F; Ye W; Kamel F Neurotoxicology; 2016 May; 54():119-126. PubMed ID: 27085208 [TBL] [Abstract][Full Text] [Related]
11. Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics. Schmidt S; Allen KD; Loiacono VT; Norman B; Stanwyck CL; Nord KM; Williams CD; Kasarskis EJ; Kamel F; McGuire V; Nelson LM; Oddone EZ Neuroepidemiology; 2008; 30(3):191-204. PubMed ID: 18421219 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for amyotrophic lateral sclerosis: A regional United States case-control study. Andrew AS; Bradley WG; Peipert D; Butt T; Amoako K; Pioro EP; Tandan R; Novak J; Quick A; Pugar KD; Sawlani K; Katirji B; Hayes TA; Cazzolli P; Gui J; Mehta P; Horton DK; Stommel EW Muscle Nerve; 2021 Jan; 63(1):52-59. PubMed ID: 33006184 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead. van Bemmel DM; Boffetta P; Liao LM; Berndt SI; Menashe I; Yeager M; Chanock S; Karami S; Zaridze D; Matteev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Slamova A; Rothman N; Han SS; Rosenberg PS; Brennan P; Chow WH; Moore LE PLoS One; 2011; 6(7):e20432. PubMed ID: 21799727 [TBL] [Abstract][Full Text] [Related]
14. Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis. O'Reilly ÉJ; Bjornevik K; Schwarzschild MA; McCullough ML; Kolonel LN; Le Marchand L; Manson JE; Ascherio A Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):194-200. PubMed ID: 29277115 [TBL] [Abstract][Full Text] [Related]
15. Lead exposure and amyotrophic lateral sclerosis. Kamel F; Umbach DM; Munsat TL; Shefner JM; Hu H; Sandler DP Epidemiology; 2002 May; 13(3):311-9. PubMed ID: 11964933 [TBL] [Abstract][Full Text] [Related]
16. Association of lead exposure with survival in amyotrophic lateral sclerosis. Kamel F; Umbach DM; Stallone L; Richards M; Hu H; Sandler DP Environ Health Perspect; 2008 Jul; 116(7):943-7. PubMed ID: 18629318 [TBL] [Abstract][Full Text] [Related]
17. Modification of the association between lead exposure and amyotrophic lateral sclerosis by iron and oxidative stress related gene polymorphisms. Eum KD; Seals RM; Taylor KM; Grespin M; Umbach DM; Hu H; Sandler DP; Kamel F; Weisskopf MG Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):72-9. PubMed ID: 25293352 [TBL] [Abstract][Full Text] [Related]
18. Lack of association of delta-aminolevulinic acid dehydratase genotype with blood lead levels in environmentally exposed children of Uygur and Han populations. Chen Y; Zhao JX; Liu JW; Cui J; Li L; Tian W Acta Paediatr; 2008 Dec; 97(12):1717-20. PubMed ID: 18795909 [TBL] [Abstract][Full Text] [Related]
19. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Schwartz BS; Lee BK; Lee GS; Stewart WF; Simon D; Kelsey K; Todd AC Environ Health Perspect; 2000 Oct; 108(10):949-54. PubMed ID: 11049814 [TBL] [Abstract][Full Text] [Related]
20. A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Smith CM; Wang X; Hu H; Kelsey KT Environ Health Perspect; 1995 Mar; 103(3):248-53. PubMed ID: 7768225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]